ArticleThe Journal of urology2015

Re: Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial.

Samir S TanejaPubMed ↗Publisher ↗

No numbers read from the abstract.